Difficulty: Medium
Average Score: 84%
Practice
Complement C3 levels are decreased in:
Correct answer
A
Rationale
In this question regarding complement C3 levels in pediatric cardiovascular disorders, the correct answer is A) Systemic lupus erythematosus (SLE). In SLE, complement C3 levels are decreased due to the activation and consumption of complement cascades as part of the immune response. This is a crucial indication of disease activity in SLE.
Option B) Henoch-Schoenlein purpura (HSP) is associated with IgA deposition in small blood vessels, leading to a different pathophysiology than complement system activation seen in SLE. Therefore, complement C3 levels are not typically decreased in HSP.
Option C) Haemolytic uremic syndrome (HUS) is characterized by microangiopathic hemolytic anemia, thrombocytopenia, and acute renal failure. While complement activation can occur in HUS, it does not typically lead to decreased complement C3 levels as seen in SLE.
Option D) Type II membrano-proliferative glomerulonephritis is a renal disorder characterized by glomerular inflammation and proliferation. While complement activation plays a role in its pathogenesis, it does not typically result in decreased complement C3 levels as in SLE.
Understanding the specific alterations in complement levels in different pediatric cardiovascular disorders is essential for nurses caring for pediatric patients. Recognizing these patterns can aid in early detection, monitoring disease progression, and guiding treatment strategies. This knowledge enhances nursing practice by promoting accurate assessment, timely intervention, and improved patient outcomes.
Option B) Henoch-Schoenlein purpura (HSP) is associated with IgA deposition in small blood vessels, leading to a different pathophysiology than complement system activation seen in SLE. Therefore, complement C3 levels are not typically decreased in HSP.
Option C) Haemolytic uremic syndrome (HUS) is characterized by microangiopathic hemolytic anemia, thrombocytopenia, and acute renal failure. While complement activation can occur in HUS, it does not typically lead to decreased complement C3 levels as seen in SLE.
Option D) Type II membrano-proliferative glomerulonephritis is a renal disorder characterized by glomerular inflammation and proliferation. While complement activation plays a role in its pathogenesis, it does not typically result in decreased complement C3 levels as in SLE.
Understanding the specific alterations in complement levels in different pediatric cardiovascular disorders is essential for nurses caring for pediatric patients. Recognizing these patterns can aid in early detection, monitoring disease progression, and guiding treatment strategies. This knowledge enhances nursing practice by promoting accurate assessment, timely intervention, and improved patient outcomes.